Jacqueline Garcia, Md

This early-stage study aims to find a safe dose for a new three-drug combination to treat acute myeloid leukemia (AML). Researchers will add an experimental drug called eganelisib to two standard medications to see if it's safe and shows early signs of helping patients. The study…